257/dao/dglp/re-04/2020-21 procurement of medicines , sodium hypochlorite 5% , chlorhexidine gluconate solution equivalent to 4 percent w/v with isopropanollt; 10 , ethoxylated alkyiphenollt; 10 fatty acid diethanolamidelt; 10 , acetic acid glaciallt; 10 , cellulose and fragrancelt; 10 500 ml bott with dispenser ( 500 ml per bott ) , 60%v/v ethyl alcohal with benzalkonium chloride , glycerine , dimethicone cyclopentasiloxane , c12- 15 alkyl lactate , proylene glycol , methylparaben , phenoxythanol , stearyl alcohol , aminomethyl propanol , diazolidinyl propanol , diazolidinyl aurea with moisturiz , 0 . 5 percent w/v chlorhexidine gluconate in 70 percent v/v ethyl alcohol with moisturizer 500 ml bott with dispenser , chloroxylenol solution potassium hydroxide-13 . 6 gm , chlaroxylenon solution 50g , oleic acid-7 . 5 %castor 011-63 . 0g , terpineal-100 ml , ethano ( 96% ) -200 ml ) purrified water freshly botled & cooled to produce 1000 ml also acceptabl chloraxy lenol-4 . 5 to 5 . 5% t , n-95 mask